LQDA
Liquidia Technologies Inc
NASDAQ: LQDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$38.15
+1.33% today
Updated 2026-04-29
Market cap
$3.39B
P/E ratio
—
P/S ratio
21.42x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$12 – $47
Volume
1.4M
Liquidia Technologies Inc (LQDA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-43.50%
Operating margin
21.50%
ROE
-111.10%
ROA
-11.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $13.22M | $-15.93M | 93.05% | -120.02% | -120.56% |
| 2017 | $7.26M | $-29.15M | 95.59% | -386.16% | -401.68% |
| 2018 | $2.71M | $-53.14M | 95.52% | -1,288.08% | -1,962.92% |
| 2019 | $8.07M | $-47.58M | 90.00% | -580.07% | -589.48% |
| 2020 | $739628.00 | $-59.76M | 67.86% | -7,989.03% | -8,080.11% |
| 2021 | $12.85M | $-34.58M | 76.48% | -262.95% | -269.03% |
| 2022 | $15.94M | $-41.02M | 82.06% | -243.30% | -257.39% |
| 2023 | $17.49M | $-78.50M | 83.49% | -419.62% | -448.89% |
| 2024 | $14.00M | $-130.39M | 58.00% | -866.63% | -931.65% |
| 2025 | $158.32M | $-68.92M | 97.21% | -32.45% | -43.53% |